MeiraGTx and Hologen Forge Groundbreaking AI-Driven Venture to Tackle Parkinson’s Disease and Obesity March 14, 2025
Revolutionizing Neuroscience: MeiraGTx and Hologen Unite for Groundbreaking AI-Driven Gene Therapy Solutions March 13, 2025
Revolutionizing Neuroscience: MeiraGTx and Hologen Forge Pioneering AI-Driven Gene Therapy Partnership March 13, 2025
Roche Strikes $1.65 Billion Deal with Zealand Pharma to Enhance Obesity Treatment Portfolio with Promising Amylin Analog March 13, 2025
Roche and Zealand Pharma Join Forces in $1.65 Billion Pact to Revolutionize Obesity Treatment March 13, 2025
Roche Partners with Zealand Pharma in Groundbreaking $1.65 Billion Obesity Treatment Deal March 13, 2025
Roche Partners with Zealand Pharma in $1.65 Billion Deal to Target the Obesity Market with Innovative Treatment Solution March 12, 2025
Roche Expands Obesity Drug Portfolio with $1.65 Billion Licensing Agreement for Promising Treatment Petrelintide March 12, 2025
Leadership Shakeup at FDA’s Device Division: Douglas Kelly’s Departure Sparks Questions on Regulatory Stability March 12, 2025
